Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001826466-23-000022
Filing Date
2023-05-15
Accepted
2023-05-15 17:22:38
Documents
36
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nika-20230331x10q.htm   iXBRL 10-Q 218255
7 EXHIBIT 31.1 nika-20230331xex31d1.htm EX-31.1 7204
8 EXHIBIT 32.1 nika-20230331xex32d1.htm EX-32.1 3284
  Complete submission text file 0001826466-23-000022.txt   1443490

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nika-20230331.xsd EX-101.SCH 12863
3 XBRL CALCULATION FILE nika-20230331_cal.xml EX-101.CAL 18703
4 XBRL DEFINITION FILE nika-20230331_def.xml EX-101.DEF 36432
5 XBRL LABEL FILE nika-20230331_lab.xml EX-101.LAB 119337
6 XBRL PRESENTATION FILE nika-20230331_pre.xml EX-101.PRE 96621
30 EXTRACTED XBRL INSTANCE DOCUMENT nika-20230331x10q_htm.xml XML 85596
Mailing Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044
Business Address 2269 MERRIMACK VALLEY AVENUE HENDERSON NV 89044 7023263615
NIKA PHARMACEUTICALS, INC (Filer) CIK: 0001145604 (see all company filings)

EIN.: 900292940 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56234 | Film No.: 23924452
SIC: 3790 Miscellaneous Transportation Equipment